ACell

ACell, Inc. is a leading regenerative medicine company dedicated to the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. ACell's core product portfolio is based on our MatriStem UBM™ platform technology. The device is an extracellular matrix that promotes the body's remodeling of functional tissue specific to the site. ACell is committed to leveraging our advanced platform technology to address complex clinical challenges in regenerative medicine, thereby maintaining its position as an innovative leader in the field of regenerative medicine technology.